{"schema_version":"1","generated_at":"2026-11-02T09:38:11.870Z","data_as_of":null,"url":"https://www.findmykol.com/kol/sagari-bette","json_url":"https://www.findmykol.com/kol/sagari-bette/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"sagari-bette","name":"Sagari Bette","credential":"MD","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"city":"Miami","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1043655657","orcid":"0000-0003-0891-2568","openalex":"A5053811490"},"summary":"Sagari Bette is a Neurology physician. OpenAlex indexes 26 publications with 276 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":26,"cited_by_count":276,"h_index":7,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":30,"program_years":{"first":2021,"last":null},"rows_total":66,"shown":3,"withheld":63,"rows":[{"payer":"Merz Pharmaceuticals, LLC","program_year":2025,"amount_usd":22212.07,"payment_count":27,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043655657"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":18042.97,"payment_count":31,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043655657"},{"payer":"MDD US Operations, LLC","program_year":2025,"amount_usd":16123.96,"payment_count":39,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043655657"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1043655657","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Musculoskeletal","share_pct":85.9,"classes_total":1,"classes":[{"class":"Neuromuscular Blocker","setting":"mixed","share_pct":85.9,"drugs":[{"name":"Onabotulinumtoxina","share_pct":63.8},{"name":"Incobotulinumtoxin a","share_pct":36.1},{"name":"Botox","share_pct":0.2}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":12.8,"classes_total":15,"classes":[{"class":"Aromatic Amino Acid Decarboxylation Inhibitor","setting":"prescribed","share_pct":5.5,"drugs":[{"name":"Carbidopa-Levodopa","share_pct":69.4},{"name":"Rytary","share_pct":22},{"name":"Carbidopa-Levodopa Er","share_pct":6.2},{"name":"Crexont","share_pct":2.4}],"max_beneficiaries":null},{"class":"Benzodiazepine","setting":"prescribed","share_pct":1.7,"drugs":[{"name":"Clonazepam","share_pct":93.1},{"name":"Lorazepam","share_pct":6.9}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":1,"classes_total":3,"classes":[{"class":"alpha-Adrenergic Agonist","setting":"prescribed","share_pct":0.4,"drugs":[{"name":"Midodrine Hcl","share_pct":100}],"max_beneficiaries":15},{"class":"Beta blocker","setting":"prescribed","share_pct":0.4,"drugs":[{"name":"Propranolol Hcl Er","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":24,"shown":5,"withheld":19,"matched_by":"OpenAlex author record","recent":[{"title":"Postural control anomalies and gait dysfunction in Tourette's syndrome: a systematic review and meta-analysis","year":2026,"journal":"Clinical Biomechanics","source_url":"https://doi.org/10.1016/j.clinbiomech.2026.106750","status":"verified"},{"title":"Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab","year":2025,"journal":"npj Digital Medicine","source_url":"https://doi.org/10.1038/s41746-025-01572-8","status":"verified"},{"title":"A Pilot Study of AI-Controlled Transcutaneous Peripheral Nerve Stimulation for Essential Tremor","year":2025,"journal":"Tremor and Other Hyperkinetic Movements","source_url":"https://doi.org/10.5334/tohm.991","status":"verified"},{"title":"Comparative safety of istradefylline in Parkinson’s disease: A systematic review of randomized controlled trials and real-world studies","year":2025,"journal":"Clinical Parkinsonism & Related Disorders","source_url":"https://doi.org/10.1016/j.prdoa.2025.100307","status":"verified"},{"title":"Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials","year":2025,"journal":"npj Parkinson s Disease","source_url":"https://doi.org/10.1038/s41531-025-01103-y","status":"verified"}],"source":"works"},"contact":{"address_1":"1150 NW 14TH ST STE 609","city":"Miami","state":"FL","zip":"331362117","phone":"305-243-1270","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1043655657","source":"identity"},"similar":[{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":63,"publications":19}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-09-19","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}